The JARED project is a Europe-wide initiative tackling one of the region’s most pressing health challenges: chronic respiratory diseases (CRDs). Our mission is to bridge critical gaps in prevention and care by scaling up proven, effective strategies across EU member states.

By building on existing best practices and adapting them to national needs, JARED empowers countries to deliver smarter, more inclusive, and more sustainable respiratory health solutions to tackle CRDs, in particular, chronic obstructive pulmonary disease (COPD).

JARED is focused on innovation, equity, and impact. Our key objectives include:

  • Driving innovation, with a strong emphasis on digital solutions to overcome resource limitations and reach more people with health promotion and prevention tools.
  • Engaging diverse communities through health literacy campaigns and other activities that help citizens understand more about their lung health and reduce their risk of CRDs.
  • Addressing health inequalities by targeting vulnerable populations who are often most exposed to risk factors—and least likely to access care.
  • Supporting national planning by creating a ready-to-use template and prototype for National Plans to prevent and manage CRDs.

The main areas of actions planned in the JARED project are the following:

  1. Strengthening and widening prevention of the onset and progress of CRDs, with a focus on COPD.
  2. Facilitating relevant vaccination programmes.
  3. Scaling-up of methods that help with the early detection of CRDs.
  4. Intensifying and improving self-management support for citizens living with CRDs, empowering them to take change of their own health.

JARED will have several targeted activities to reach vulnerable populations, aiming at reducing health inequalities.

Work Packages (WP)

  • WP1: Coordination and project management

    WP1 will ensure the effective and efficient management and implementation of all project activities. It will focus on the project objectives according to the time schedule, budget and the quality standards established in line with the contractual obligations.

  • WP2: Communication, dissemination and awareness raising

    WP2 will disseminate information about all the activities and outcomes of the project and inform and engage all the related stakeholders.  It will work on the project’s dissemination, communication and outreach strategy.

  • WP3: Evaluation

    WP3 will assess the project’s performance and impact. It will monitor the project’s implementation, it will evaluate the activities in terms of process adherence, output, outcome, and impact based on an evaluation plan to be developed. It will provide support to all aspects of project implementation, monitoring and achievement of outcomes.

  • WP4: Sustainability

    WP4 will focus on ensuring the long-term effectiveness of activities to decrease the burden of CRDs, fostering robust stakeholder engagements and partnerships, securing continuous funding for ongoing activities, influencing public health policies for broader implementation of project findings, and prioritizing health equity to address disparities in CRD care.

  • WP5: Prevention of CRDs with focus on early lung development

    WP5 wil provide solutions for vaccination uptake, it will enhance respiratory disease prevention, it will offer methodological assistance to schools for smoking prevention of smoking of tobacco, as well as solutions for reducing the risk of early life exposure to air pollutants and for preventing the aggravation of chronic respiratory diseases caused by exposure to air pollutants. Finally, it will provide solutions for the prevention of respiratory infections in long-term social care institutions.

  • WP6: Early detection, diagnosis and treatment of chronic respiratory diseases

    WP6 will focus on improving early detection and treatment of asthma, COPD, and other lung diseases, particularly in primary health care. It will increase awareness among healthcare professionals, it will enhance diagnostic skills through spirometry and screening tools, and it will strengthen cooperation between primary and secondary care. WP6 will also promote the appropriate use of anti-inflammatory treatment in mild asthma, improve patient education for better self-management, and develop structured asthma and COPD programs. One of its priorities will be to support elderly patients with COPD and asthma through digital solutions.

  • WP7: Living with chronic respiratory diseases – a life-span approach

    WP7 will focus on the innovative and patient-centred approaches to all the major aspects of living with COPD and other CRDs, and also to fight lack of understanding, communication gaps and stigmatisation, enabling social interactions and encouraging gatherings of patient groups (local or virtual) by means of digital solutions and multidisciplinary work.

  • WP8: Reach-out to high-risk vulnerable people

    WP8 will enhance awareness, health literacy and self-management related to CRDs in vulnerable (i.e., socially deprived, migrants, ethnic minorities) and remote populations. It will facilitate access of remote populations to health care services through telemedicine and it will improve self- and workplace management of workers exposed to occupational and environmental CRDs risk factors. Furthermore, it will develop a feasible health surveillance strategy for the early detection of work-related asthma. It will also develop educational materials and implement training courses focusing on CRDs for health care personnel.